NEW YORK (GenomeWeb News) – Boreal Genomics said today that it has completed an $18 million Series C financing round, which will be used to expand its commercial operations and launch clinical applications.

Participants in the financing round included existing investors Arch Venture Partners and Kearny Venture Partners. New undisclosed strategic and private investors also participated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.